Skip to main content
Erschienen in: Pediatric Rheumatology 1/2021

Open Access 01.12.2021 | Commentary

Pediatric rheumatology in Africa: thriving amidst challenges

verfasst von: Angela N. Migowa, Djohra Hadef, Wafa Hamdi, Oscar Mwizerwa, Madeleine Ngandeu, Yassmin Taha, Faleye Ayodele, Kate Webb, Christiaan Scott

Erschienen in: Pediatric Rheumatology | Ausgabe 1/2021

Abstract

Background

Pediatric Rheumatology is an orphan specialty in Africa which is gradually gaining importance across the continent.

Main body

This commentary discusses the current state of affairs in the sphere of Pediatric Rheumatology across Africa and offers practical strategies to navigate the challenges encountered in research, models of care, education and training. We outline the establishment, opportunities of growth and achievements of the Pediatric Society of the African League Against Rheumatism (PAFLAR).

Conclusion

This commentary lays the foundation for establishment of a formidable framework and development of partnerships for the prosperity of Pediatric Rheumatology in Africa and beyond.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Africa is the second most populous continent in the world with an estimated 1.2 billion people and 496 million children [1, 2]. The pediatric population in Africa is postulated to rise to 661 million by 2030, becoming the continent with the most children [2]. There are approximately 6–7 million children afflicted worldwide with rheumatic disease and the majority of these, approximately 78%, live in Asia and Africa [35]. Rheumatic diseases often result in pain, disability, poor mental health and increased all-cause mortality [6]. Pediatric Rheumatic Diseases (PRDs) are perceived to be rare in Africa probably due to lack of local expertise and reporting [35]. In reality, there are significant numbers of children with rheumatic diseases in Africa who deserve care [35]. Acknowledging the burden of pediatric rheumatic diseases across Africa is an important critical step in providing care to these patients [715]. As we strive to achieve universal healthcare, non-communicable diseases such as PRDs require attention [1618]. Developing the pediatric rheumatology workforce is a prerequisite to providing children with rheumatic diseases access to healthcare and good clinical outcomes [19]. Significant strides have been made to promote the discipline of Pediatric rheumatology in Africa as evidenced by the various centers that exist in the 10 of the 54 countries in Africa illustrated in Table 1 and Fig. 1. However much more still needs to be done to establish pediatric rheumatology services across the continent.
Table 1
Overview of Paediatric Rheumatology Centres in Africa
Country
Centre
Paediatric Rheumatologist
Contacts
Training Centre
Inpatients
/year
Outpatient/year
Availability of Occupational Therapy/Physiotherapy
Availability of Synthetic DMARDs
Availability of Biological DMARDs
Northern Africa Region
1.Egypt
Abu el Reesh University Hospital
Hala M Lofty
Dr_hlofty@yahoo.com
Cairo University
EULAR Courses
600
8000
Available
Available
Ant TNF
Anti IL1
Anti IL6
Anti IL17
Anti IL23
JAK Inhibitors
Anti CD 20
2.Libya
Benghazi Children Hospital
Halima Mohamed Benamer
benamer_h@yahoo,co.uk
Benghazi Children Hospital
50
300
Available
Available
Ant TNF
Anti IL1
Anti IL6
Anti CD 20
Tripoli Children’s Hospital
1.Soad Hashad
2.Hala Etayari
3.Eman Elmisllati-Traineee
4.Magda Tofil-Trainee
5.Zohairah Awhidah-Trainee
6.Aya Twati-Trainee
soadhashad@hotmail.com
h.eltayari@uot.edu.ly
dr.iman.misllati@gmail.com
magdanaltfyl@gmail.com
zohairah.awhaidah11@gmail.com
Tripoli Children’s Hospital
Instituto Giannina Gaslini, Genoa/Italy
EULAR Online Course
20
800
3.Tunisia
-Kassab Institute / Manouba
-Mongi Slim Hospital Tunis
-Children hospital Bechir Hamza / Tunis
Wafa HAMDI
Leila Souabni
Zohra Fitouri
wafahamdi6@yahoo.fr
Paris-Descartes University FRANCE
150
600
Available
Available
Anti TNF (5 molecules)
Anti IL6
JAK Inhibitors
Anti CD20
Anti IL17
4.Algeria
Batna 2 University
Djohra HADEF
djohra.hadef@paflar.org
France
30
100
Available
Available
Ant TNF
Anti IL1
Anti IL6
Anti IL17
Anti CD 20
Eastern Africa Region
5.Kenya
Aga Khan University Medical College East Africa
Angela Migowa
angela.migowa@
angela.migowa@aku.edu
McGill University Health Centre
30
200
Available
Available
Ant TNF
Anti IL1
Anti IL6
JAK Inhibitors
Anti CD 20
University of Nairobi
Lawrence Owino
jahkaruoth2000@gmail.com
University of Cape Town
50
300
6.Tanzania
Dar es Salaam
Francis Fredrick
fredrick.francis78@gmail.com
EULAR Online Course
University of Cape Town
50
300
Available
Available
Anti CD 20
Anti IL6
7.Sudan
Khartoum
Abubaker Fadlelmola
ytaha@doctors.org.uk
University of Cape Town
100
400
Available
Available
Inaccessible
Yassmin Taha
United Kingdom
Western Africa Region
8.Nigeria
Lagos State University Teaching Hospital
Faleye Ayodele
faleyeayo2013@gmail.com
University of Cape Town
10–20
40
  
Anti TNF
Anti CD 20
9.Ghana
Tamale
Yaninga Halwani Fusweni
yaninga@yahoo.com
University of Cape Town
6
5
Available
Available
Inaccessible
Southern Africa Region
10.South Africa
University of Cape Town
Chris Scott
chris.scott@uct.ac.za
South Africa and Belgium
450
1500
Available
Available
Ant TNF
Anti IL1
Anti IL6
JAK Inhibitors
Anti CD 20
Kate Webb
drkatewebb@gmail.com
South Africa and UK
Nicky Brice
 
University of Cape Town
Waheba Slamang
waheba.slamang@gmail.com
University of Cape Town
Deepthi Abraham
deepthi@sun.ac.za
Tygerberg Hospital
113
516
Johannesburg
Gail Faller
gail.faller8@live.com
University of Witwatersrand
20–40
200
Bhadrish Mistry
bjmistry@mweb.co.za
University of Western Australia
20–40
200
Priya Ambaram
priya.ambaram@gmail.com
University of Witwatersrand
4–20
395
Durban
Kogie Chinniah
chinniahk2@ukzn.ac.za
Nelson R Mandela School of Medicine
60
560

The current state of pediatric rheumatology in Africa

A. Research

Epidemiological data concerning PRDs among children across Africa is scarce [20]. There are insufficient resources for research [2123]. There is considerably less industry support in African countries [24, 25]. Studies from Africa are mostly hospital-based case series and may lack applicability to the community [26].
Despite the challenges, there are deliberate efforts to bridge the research gap in pediatric rheumatology across Africa [2227]. Research has been carried out in the field of lupus and juvenile idiopathic arthritis among other rheumatic diseases [1, 11, 1927]. It is imperative that we not only describe the disease phenotypes but aim to include our patients in biological research.
In Kenya and South Africa for example, there are nationwide collaborative studies on Multisystem Inflammatory Syndrome in Children (MIS-C) in order to describe the clinico-epidemiological characteristics and outcomes of MIS-C [28]. The African League Against Rheumatism (AFLAR) study on COVID-19 showed the benefits of pulling together both adult and pediatric rheumatologists to work on a common research agenda for the continent [29]. This is an indicator of the potential for more research collaborations among member countries of the AFLAR involving both pediatric and adult rheumatologists [29].
One of the key pillars in PAFLAR’s strategic plan is to build research by promoting collaborative efforts, establishment of registries, an ethical review board and a journal to showcase research from Africa. This shall be spearheaded by the existing PAFLAR Scientific Committee.

B. Models of Care

Telemedicine

There is a paucity of medical personnel across Africa with only 2.7 physicians per 10,000 people in Africa compared to 5.9 in South East Asia, 12.7 in the eastern Mediterranean, 15.5 in the Western Pacific, 21.5 in the Americas, and 32.1 in the European region [30]. Retention of trained specialists poses a challenge in Africa due to a lack of supportive frameworks and ‘brain drain’ [31]. This is challenging particularly when health systems are strained. Telemedicine offers a plausible solution [32]. Recently, there has been increased access to and reliance on remote meeting systems [33]. Tele-consults through platforms such as zoom can be used to enhance multi-disciplinary care for patients. Pediatric rheumatology teams in Nigeria and Kenya for example organize zoom meetings on a need to need basis to discuss and deliberate on patients they mutually have in common in a multi-disciplinary approach. Further research is required to explore how best to utilize telemedicine to promote pediatric rheumatology in Africa. In solidarity with global partners, researchers from Africa are participating in the validation of the virtual pediatric gait, arms, leg, spine (PGALS) screening examination as part of a global telemedicine initiative [33]. More research is needed to explore the feasibility of telemedicine for pediatric rheumatology in Africa.

C. Education and Training

I) PAFLAR Webinars

Since its establishment on September 7th, 2019, the Pediatric Society of the African League Against Rheumatism (PAFLAR) embarked on a series of webinars from the 5 regions of Africa i.e. northern, eastern, southern, central and western regions to help bridge the gap in pediatric rheumatology education. This has helped bring the pediatric rheumatology family in Africa much closer allowing exchange of knowledge where distance has been bridged by digital technology. This also serves as a platform to begin academic mentorship of pediatric trainees who log onto the webinars. In order to expand its reach, PAFLAR shall be collaborating with the Juvenile Inflammatory Rheumatism (JIR) winter school in Switzerland through facilitation of an ILAR grant to offer virtual conferences and webinars to members of both PAFLAR and JIR. The goal is to offer a blended learning experience by combining our PAFLAR webinars and the JIR rheumatology courses through fee subsidies to enrich the learning experience of pediatric rheumatologists and all other healthcare workers who care for pediatric rheumatology patients in the African continent while offering them an opportunity to showcase their clinical experience and expertise with the global rheumatology community.

II) Pediatric Rheumatology Training

There have been various initiatives to help bridge the gap in the pediatric rheumatology workforce [3437]. This includes the UWEZO project, a collaboration between Kenyan, United Kingdom (UK) and Swedish rheumatologists who trained an estimated 500 physicians and health workers at 11 sites across Kenya [38]. The International League of Associations for Rheumatology (ILAR) supported onsite training in Zambia for 2 years under the EPAREP project (Enhancement of Pediatric and Adult Rheumatology Education and Practice) [39].
In early 2009, the International League of Associations for Rheumatology (ILAR) funded a program known as the “East Africa Initiative” in order to unite the international rheumatology community to promote rheumatology services in an area that carries 25% of the world’s disease burden but has only 2% of the world’s human resources for health [40]. Consequently, training for the only 2 pediatric rheumatologists in East and Central Africa, who are based in Kenya, was supported by rheumatology units in the United Kingdom (UK,) Canada and South Africa. Collaborations have spurred the growth of pediatric rheumatology in Africa through foundations such as “Rheumatology for All” with outreach activities in Ethiopia and Rwanda (https://​rheumatologyfora​ll.​org).
Developing hybrid programs of local and international training, as occurs in Kuwait and Saudi Arabia, may be more feasible and sustainable [14, 15]. The Pediatric Rheumatology European Society (PReS) and other bodies may look to set up “sister hospital initiatives” where “areas of need” partner with well-resourced hospitals to provide education and clinical support. A similar initiative was successfully undertaken as part of the southern hemisphere educational partnership for pediatric arthritis and rheumatological diseases (SHEPPARD) program between Argentina and South Africa [34]. These kinds of activities happen informally all the time, but a centralized or regional system would enable people to access them more easily.

Conclusion

This is a long journey which has already started and is gaining momentum. Initiatives such as the creation of a Pediatric Society of the African League Against Rheumatism (PAFLAR), the creation of Global Task Force for Musculoskeletal Health and PReS (Pediatric Rheumatology European Society) initiatives indicate that a core group of rheumatology health care providers and indeed the global community, have recognized that reaching out to the millions of children who live with rheumatic diseases in areas or situations where appropriate care is unavailable or inaccessible is a moral imperative.

Acknowledgements

We thank Hala M Lofty, Halima Mohamed Benamer, Soad Hashad, Hala Etayari, Lawrence Owino, Yaninga Halwani Fusweni and Gail Faller for sharing an overview of Pediatric Rheumatology in their respective countries.

Declarations

Ethical approval was not deemed appropriate for this study. Consent from patients is not applicable in this article.
All authors give consent for publication.

Competing interests

The authors declare that they have no competing interests. The authors have no financial relationships relevant to this article to disclose.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Dave M, Rankin J, Pearce M, Foster HE. Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. PediatrRheumatol Online J. 2020;18(1):49. Dave M, Rankin J, Pearce M, Foster HE. Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. PediatrRheumatol Online J. 2020;18(1):49.
5.
Zurück zum Zitat Foster HE, Scott C, Tiderius CJ, Dobbs MB. Members of the Paediatric global musculoskeletal task F. improving musculoskeletal health for children and young people - A 'call to action'. Best Pract Res Clin Rheumatol. 2020;101566. Foster HE, Scott C, Tiderius CJ, Dobbs MB. Members of the Paediatric global musculoskeletal task F. improving musculoskeletal health for children and young people - A 'call to action'. Best Pract Res Clin Rheumatol. 2020;101566.
6.
Zurück zum Zitat Tyrovolas S, Moneta V, Gine Vazquez I, Koyanagi A, Abduljabbar AS, Haro JM. Mental Disorders, Musculoskeletal Disorders and Income-Driven Patterns: Evidence from the Global Burden of Disease Study 2017. J Clin Med. 2020;9:7.CrossRef Tyrovolas S, Moneta V, Gine Vazquez I, Koyanagi A, Abduljabbar AS, Haro JM. Mental Disorders, Musculoskeletal Disorders and Income-Driven Patterns: Evidence from the Global Burden of Disease Study 2017. J Clin Med. 2020;9:7.CrossRef
16.
Zurück zum Zitat Henrickson M. Policy challenges for the pediatric rheumatology workforce: part II. Health care system delivery and workforce supply. Pediatr Rheumatol Online J. 2011;9:24.CrossRef Henrickson M. Policy challenges for the pediatric rheumatology workforce: part II. Health care system delivery and workforce supply. Pediatr Rheumatol Online J. 2011;9:24.CrossRef
17.
Zurück zum Zitat Henrickson M. Policy challenges for the pediatric rheumatology workforce: Part III. the international situation. PediatrRheumatol Online J. 2011;9:26. Henrickson M. Policy challenges for the pediatric rheumatology workforce: Part III. the international situation. PediatrRheumatol Online J. 2011;9:26.
18.
Zurück zum Zitat Henrickson M. Policy challenges for the pediatric rheumatology workforce: part I. Education and economics. PediatrRheumatol Online J. 2011;9:23. Henrickson M. Policy challenges for the pediatric rheumatology workforce: part I. Education and economics. PediatrRheumatol Online J. 2011;9:23.
22.
Zurück zum Zitat Migowa A, Colmegna I, Hitchon C, Were E, Ng'ang'a E, Ngwiri T, et al. The spectrum of rheumatic in-patient diagnoses at a pediatric hospital in Kenya. PediatrRheumatol Online J. 2017;15(1):4. Migowa A, Colmegna I, Hitchon C, Were E, Ng'ang'a E, Ngwiri T, et al. The spectrum of rheumatic in-patient diagnoses at a pediatric hospital in Kenya. PediatrRheumatol Online J. 2017;15(1):4.
25.
Zurück zum Zitat Adebajo AO. Rheumatology and Africa. Trop Dr. 1992;22(2):86. Adebajo AO. Rheumatology and Africa. Trop Dr. 1992;22(2):86.
26.
Zurück zum Zitat Adebajo AO, Hazleman BL. Tropical rheumatology--time for action. World Health Forum. 1993;14(3):293.PubMed Adebajo AO, Hazleman BL. Tropical rheumatology--time for action. World Health Forum. 1993;14(3):293.PubMed
31.
Zurück zum Zitat Anton JLM, Cuadros EN. Paediatric rheumatology:where we are coming from and where we are going. Ann Pediatr (Barc). 2020;92(3):3.CrossRef Anton JLM, Cuadros EN. Paediatric rheumatology:where we are coming from and where we are going. Ann Pediatr (Barc). 2020;92(3):3.CrossRef
34.
Zurück zum Zitat Russo RA, Katsicas MM, Webb K, Scott C. Southern hemisphere educational partnership for pediatric arthritis and rheumatological diseases (Sheppard): pediatric rheumatology without borders. Pediatric Rheumatology. 2013;11(Suppl 2):O30.CrossRef Russo RA, Katsicas MM, Webb K, Scott C. Southern hemisphere educational partnership for pediatric arthritis and rheumatological diseases (Sheppard): pediatric rheumatology without borders. Pediatric Rheumatology. 2013;11(Suppl 2):O30.CrossRef
39.
Zurück zum Zitat Chipeta JNP, McGill PE, Bucala R. Progress made towards enhancement of rheumatology education and practice in Zambia: review of an ILAR supported project. Clin Rheumatol. 2014;33:6.CrossRef Chipeta JNP, McGill PE, Bucala R. Progress made towards enhancement of rheumatology education and practice in Zambia: review of an ILAR supported project. Clin Rheumatol. 2014;33:6.CrossRef
40.
Zurück zum Zitat Colmegna IBS, Oyoo OG. The ILAR East Africa initiative: current needs and progress in the globalization of rheumatology. Clin Rheumatol. 2011;30(2):3.CrossRef Colmegna IBS, Oyoo OG. The ILAR East Africa initiative: current needs and progress in the globalization of rheumatology. Clin Rheumatol. 2011;30(2):3.CrossRef
Metadaten
Titel
Pediatric rheumatology in Africa: thriving amidst challenges
verfasst von
Angela N. Migowa
Djohra Hadef
Wafa Hamdi
Oscar Mwizerwa
Madeleine Ngandeu
Yassmin Taha
Faleye Ayodele
Kate Webb
Christiaan Scott
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Pediatric Rheumatology / Ausgabe 1/2021
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-021-00557-7

Weitere Artikel der Ausgabe 1/2021

Pediatric Rheumatology 1/2021 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.